Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

71.06
+1.241.78%
Post-market: 70.50-0.5623-0.79%16:12 EDT
Volume:897.68K
Turnover:63.18M
Market Cap:5.93B
PE:-116.49
High:71.45
Open:69.67
Low:68.02
Close:69.82
52wk High:90.87
52wk Low:48.28
Shares:83.46M
Float Shares:77.19M
Volume Ratio:0.95
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.86
PE(LYR):9.13

Loading ...

PTC Therapeutics price target lowered to $93 from $95 at Wells Fargo

TIPRANKS
·
Jul 20

PTC Therapeutics Schedules Second-quarter 2026 Results Webcast Conference Call

Reuters
·
Jul 16

PTC Therapeutics is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 16

PTC Therapeutics price target raised to $130 from $124 at Cantor Fitzgerald

TIPRANKS
·
Jul 16

PTC Therapeutics price target raised to $95 from $93 at BofA

TIPRANKS
·
Jul 15

U.S. Research Roundup-equinix, Goldman Sachs, Jpmorgan

Reuters
·
Jul 15

PTC Therapeutics Director Mary L. Smith Disposes of USD 1.43 Million in Common Shares

Reuters
·
Jul 14

PTC Therapeutics EVP, CLO Mark Elliott Boulding Disposes of Common Shares Worth $257,864.88

Reuters
·
Jul 09

Barclays Remains a Buy on PTC Therapeutics (PTCT)

TIPRANKS
·
Jul 08

PTC Therapeutics is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jul 07

RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Does Triple Russell 2000 Defensive Index Inclusion Reframe PTC Therapeutics’ Risk Profile And Rare-Disease Story (PTCT)?

Simply Wall St.
·
Jul 07

PTC Therapeutics Chief Technical Ops Officer Neil Gregory Almstead Disposes of 8,130 Common Shares Worth $692,193.06

Reuters
·
Jul 01

PTC Therapeutics Chief Technical Ops Officer Neil Gregory Almstead Sells USD 3.32 Million in Common Shares

Reuters
·
Jun 27

PTC Therapeutics Chief Technical Ops Officer Neil Gregory Almstead Disposes of 23,749 Common Shares Worth $1.95 Million

Reuters
·
Jun 25

PTC Therapeutics Exec VP, CLO Mark Elliott Boulding disposes of 10,462 common shares worth $823,540

Reuters
·
Jun 23

PTC Therapeutics Completes Major Convertible Notes Offering

TIPRANKS
·
Jun 19

PTC Therapeutics prices USD 550 million zero-coupon convertible notes due 2031

Reuters
·
Jun 19

PTC Therapeutics (PTCT) Stock Could Be 14% Undervalued After $500 Million Note Refinancing

Simply Wall St.
·
Jun 19

PTC Therapeutics grants inducement equity awards to 18 new hires

Reuters
·
Jun 18